Development of a GPR23 cell-based β-lactamase reporter assay

Paul H Lee1, Bonnie J Hanson

  • 1Lead Discovery, Amgen, Inc., Thousand Oaks, California, USA.

Methods in Enzymology
|November 6, 2010
PubMed
Summary

Researchers identified the first small molecule inverse agonists for G protein-coupled receptor 23 (GPR23), a key player in neurodevelopment. This discovery provides crucial tools for understanding GPR23

Related Concept Videos